FRESTEDT INC KEEPS GROWING: Josh Myers has joined our team! Author: Frestedt Incorporated
6JUL2019 Saint Louis Park, MN – Frestedt Incorporated
Frestedt Inc., recently named “2019 Company of the Year” by Pharma Tech Outlook, has grown significantly in the past year. Growing in business coming in and also expanding the Frestedt team. We are pleased to announce Josh Myers has joined the Frestedt Inc. team as Clinical, Regulatory, Quality and Engineering (CRQE) Manager. Josh will be a hands-on manager helping the team to grow and develop further. Josh holds a Master’s degree in Biomedical Engineering from University of Iowa and has experience as Director of Clinical Operations, Clinical Operations Manager, Clinical Study/Trial Manager, Senior Clinical Research Associate and Clinical Studies Coordinator. Dr. Frestedt (President and CEO of Frestedt Inc. and Alimentix) commented, “We are delighted to have Josh onboard as a key contributor! Josh brings 15 years in clinical industries. Josh is a clinical research expert and we are excited to have his expertise merged in with our team.”
About Frestedt Inc.
Frestedt Incorporated (www.frestedt.com) is an unparalleled consortium of nine full time staff and over 70 knowledge experts working in an innovative, virtual setting to keep our service quality of the highest caliber and our costs as low as possible. Frestedt Incorporated works to solve problems with a forward-thinking approach designed to provide all deliverables within tight timelines and budgets. We are a dynamic partner, focused on providing exactly the right solution to meet our client’s needs and we hold ourselves to the highest standards in everything we do. We provide support in running clinical trials and negotiating with regulatory authorities, and we build quality systems, training sessions and engineering services designed to secure the success of our client’s products in the US and global markets.
Ali Schulz Executive Assistant email@example.com